Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 14;19(1):138.
doi: 10.1186/s12882-018-0933-2.

Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study

Liu Yang  1 , Honglang Xie  1 , Zhengzhao Liu  1 , Yinghua Chen  1 , Jinquan Wang  1 , Haitao Zhang  1 , Yongchun Ge  2 , Weixin Hu  3
Affiliations

Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study

Liu Yang et al. BMC Nephrol. .

Abstract

Background: Severe infections are common complications of immunosuppressive treatment for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with renal involvement. We investigated the clinical characteristics and risk factors of severe infection in Chinese patients with AAV after immunosuppressive therapy.

Methods: A total of 248 patients with a new diagnosis of ANCA-associated vasculitis were included in this study. The incidence, time, site, and risk factors of severe infection by the induction therapies were analysed. Multivariate Cox proportional hazards models were used to calculate hazard ratios (HRs) with 95% confidence intervals (CI).

Results: A total of 103 episodes of severe infection were identified in 86 (34.7%, 86/248) patients during a median follow-up of 15 months. The incidence of infection during induction therapy was 38.5% for corticosteroids (CS), 39.0% for CS+ intravenous cyclophosphamide (IV-CYC), 33.8% for CS+ mycophenolate mofetil and 22.5% for CS + tripterygium glycosides, 76 (73.8%) infection episodes occurred within 6 months, while 66 (64.1%) occurred within 3 months. Pneumonia (71.8%, 74/103) was the most frequent type of infection, and the main pathogenic spectrum included bacteria (78.6%), fungi (12.6%), and viruses (8.7%). The risk factors associated with infection were age at the time of diagnosis (HR = 1.003, 95% CI = 1.000-1.006), smoking (HR = 2.338, 95% CI = 1.236-4.424), baseline secrum creatinine (SCr) ≥5.74 mg/dl (HR = 2.153, 95% CI = 1.323-3.502), CD4+ T cell< 281 μl (HR = 1.813, 95% CI = 1.133-2.900), and intravenous cyclophosphamide regimen (HR = 1.951, 95% CI =1.520-2.740). Twelve (13.9%) patients died of severe pneumonia.

Conclusion: The infection rate during induction therapy was high in patients with AAV. Bacterial pneumonia was the main type of infection encountered. Age at the time of diagnosis, smoking, baseline SCr ≥5.74 mg/dl, CD4+ T cell< 281 μl, and IV-CYC therapy were identified as risk factors for infection.

Keywords: Anti-neutrophil cytoplasmic antibody; Infection; Lung; Risk factors; Vasculitis.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study was approved by Ethics Committee of Jinling Hospital (Nanjing, China). Written consent was obtained from each participant. Declaration of Helsinki was followed while conducting this analysis.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing of interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Charlier C, Henegar C, Launay O, Pagnoux C, Berezne A, Bienvenu B, et al. Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis. 2009;68(5):658–663. doi: 10.1136/ard.2008.088302. - DOI - PubMed
    1. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, et al. An interdisciplinary approach to the care of patients with Wegener’s granulomatosis-long-term outcome in 155 patients. Arthritis Rheum. 2000;43(5):1021–1032. doi: 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J. - DOI - PubMed
    1. Gavraud M, Guillevin L, Le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44(3):666–675. doi: 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A. - DOI - PubMed
    1. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70(3):488–494. doi: 10.1136/ard.2010.137778. - DOI - PubMed
    1. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. AnnRheum Dis. 2009;68(3):310–317. doi: 10.1136/ard.2008.088096. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources